ArticleThe oncologist2019

Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses.

Hyungwoo Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.